Elafibranor
Genfit SA
[]
$gnft: elafibranor phase 3 data in pbc - q2'23
$qure: amt-130 ph1/2 data update in huntington's - q2'23 conferences
#aacr23: 14-19 apr #eccmid23: 15-18 apr
#ishlt2023: 19-22 apr
#asa23conf: 19-23 apr
#aan2023: 22-28 apr (2/2)
Life Sciences Equities team of Van Lanschot Kempen Investment Banking, leading in European Life Sciences. Follow us for our latest activities! | @VLKCorporate